Skip to content
OpenCapital
Get started

Cardinal Health CAH Pharmaceutical and Specialty Solutions — Revenue

Other segment segments

Cost of product sold
$3.15B-0.4%
Other Segments
$1.71B+30.8%

Similar metrics at other companies

Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Net revenue
$133.27M+23.1%
HWK
HWKNPharmaceutical — Revenue
$8.32M+15.1%
Cencora logo
COROther Healthcare Solutions — Revenue
$1.05B+13.5%
Kiniksa Pharmaceuticals International, plc logo
KNSAPharmaceutical — Revenue
$214.27M+55.5%
The Oncology Institute, Inc. logo
TOISpecialty Pharmacy — Total operating revenue
$87.54M+77.6%
Chart Industries logo
GTLSSpecialty Products — Sales
$214.5M-22.3%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$54.98B+41.0%
Enterprise value$59.96B+38.3%
P/E35.4×+10.3×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%—
Debt / equity4.1×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's pharmaceutical and specialty solutions — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's pharmaceutical and specialty solutions — revenue?
Cardinal Health (CAH) reported pharmaceutical and specialty solutions — revenue of $56.11B in Q1 2026.
How has Cardinal Health's pharmaceutical and specialty solutions — revenue changed year-over-year?
Cardinal Health's pharmaceutical and specialty solutions — revenue increased by 11.3% year-over-year, from $50.43B to $56.11B.
What is the long-term trend for Cardinal Health's pharmaceutical and specialty solutions — revenue?
Over 2 years (2022 to 2025), Cardinal Health's pharmaceutical and specialty solutions — revenue has grown at a 11.5% compound annual growth rate (CAGR), from $164.6B to $204.64B.
What does pharmaceutical and specialty solutions — revenue mean?
The total gross sales generated from the distribution of branded, generic, and specialty pharmaceutical products to healthcare providers and pharmacies within this segment. This is the primary top-line metric for the business unit, reflecting volume and pricing power in the pharmaceutical supply chain. It excludes intersegment eliminations to show the segment's external market footprint.